News

Today's video focuses on Roku's (NASDAQ: ROKU) earnings, reported on Nov. 3, after the market closed, and why its stock price dropped. Here are some highlights from the video. 

Click the video below

As an investor, you're in the business of predicting the future. No matter how good you are at analyzing business trends and projecting consumer behaviors to come, there is a certain amount of luck

Real estate titans Sam Zell and Barry Sternlicht had been fighting over industrial REIT Monmouth Real Estate Investment (NYSE: MNR). While Monmouth's board agreed to a cash-and-stock deal with

Cirrus Logic's (NASDAQ: CRUS) fiscal 2022 second-quarter results cruised past Wall Street's expectations. The company reported solid growth in its top and bottom lines on Nov. 1, thanks to the

Today's video focuses on DraftKings (NASDAQ:DKNG) and an update on its earnings reported on Nov. 5 before the market opened. Here are some highlights from the video. 

Click the video below for my

It's been a tough year for Lemonade (NYSE: LMND) investors. Share prices of the strangely named insurance technology company are down more than 60% from their January peak and are still within reach

Fantasy sports company DraftKings (NASDAQ: DKNG) has crushed the market average since the beginning of 2020, up nearly 400% during this short time. Investors are cheering the company's robust growth

If you like stories of intrigue and unexpected plot twists, you've come to the right place. AMC Entertainment Holdings (NYSE: AMC) reports fresh financial results this week, shortly after Monday's

Occasional stock market meltdowns are inevitable. If you're going to be a stock investor hoping for great long-term gains, you'll have to accept that -- and expect corrections and crashes every few

Shares of Sibanye Stillwater (NYSE: SBSW) jumped 15.1% in October, according to data provided by S&P Global Market Intelligence. Several factors fueled the precious metal mining stock's rally,

The stock market is an exciting place filled with innovative companies reshaping our future. History shows that a long-term approach to the market yields the best returns, evidenced by the 3,700%

Shares of the messenger RNA (mRNA) drug and vaccine developer Moderna (NASDAQ: MRNA) slipped by a noteworthy 10.7% during the month of October, according to data from S&P Global Market Intelligence

Goldman Sachs (NYSE: GS) released its third-quarter earnings in mid-October, continuing a massively successful year for the investment banking giant. In this Fool Live clip, recorded on Oct. 18

If you feel like valuations on Wall Street have grown a little too frothy over the course of the past few months, you're not crazy. Up by more than 100% since its March 2020 low, the S&P 500

Shares of the pharma giant Merck (NYSE: MRK) rose by 17.2% over the course of October, according to data from S&P Global Market Intelligence. The drugmaker's stock caught fire last month for two

I've been picking stocks to avoid every week, identifying names that I think could be challenged in the coming days. My three stocks to avoid last week were on the move -- down 17%, down 13%, and up

Shares of cloud-based data warehousing company Snowflake (NYSE: SNOW) surged 17% in October, according to data from S&P Global Market Intelligence.

Snowflake didn't report earnings in October, but

Shares of property technology company Latch (NASDAQ: LTCH) fell 21.1% in October, according to data from S&P Global Market Intelligence.

There wasn't much in the way of company-specific news during

Shares of Arista Networks (NYSE: ANET) rose 19.2% in October, according to data from S&P Global Market Intelligence.

The company didn't report earnings until November, which proved to be another

After taking on billions in debt to weather the 2020 economic storms of COVID-19, Ford (NYSE: F) announced on Nov. 4 that it's freeing itself from approximately $5 billion worth of junk bonds

Shares of Protagonist Therapeutics (NASDAQ: PTGX) soared 80.2% in October, according to data from S&P Global Market Intelligence. The stock surged after the U.S. Food and Drug Administration (FDA)

The term "value stock" often refers to companies that trade at cheap valuations in relation to their annual earnings or cash flows. While many of these companies are valued cheaply due to slow or

Arguably the hottest sector in commercial real estate (CRE) right now is industrial real estate. Not only has industrial real estate on average outperformed all other real estate sectors for the

Sturm, Ruger (NYSE: RGR) investors might have been surprised to see that even though the company's fiscal third-quarter firearms sales jumped 22% year over year and per-share profits were 42%